RE: High Noon8 Dec 2025 10:48
BBB11 I was typing another reply to NP, but yours sums it up nicely. NP is not neutral fact checking at all. An investor into a biotech share that's made many hugely positive steps on science and in 3 patients so far isn't coming here on the basis that the treatment doesn't work. This is a risk investment, always has been...every biotech is. No one is investing here for the downside - the risk is always there, but it is not their base case. They are here as their base case is that it does work or worst case looks more and more positive and appears to be working. NP may highlight a potential risk or potential issue or a gap but then they will contort themselves to try and entrench that risk as the investment base case. If they were balanced highlighting both sides of the equation / ie either side of the base case, they'd have some credibility. But we know they don't.